Affinity Asset Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 87 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 94 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 87 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 50 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 46 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 55 |
|
|
2021
Q1 | – | Sell |
-3,500
| Closed | -$536K | – | 65 |
|
|
2020
Q4 | $536K | Buy |
+3,500
| New | +$536K | 0.28% | 53 |
|